Clinical Trials Browser

Not yet recruiting × Gastric/Gastroesophageal Junction Adenocarcinoma × tislelizumab × Clear all

NCT06764251 2025-01-08

Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Gastric/Gastroesophageal Junction Adenocarcinoma